Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novartis AG Common Stock
(NY:
NVS
)
131.26
-0.65 (-0.49%)
Official Closing Price
Updated: 7:00 PM EST, Nov 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,822,810
Open
132.46
Bid (Size)
128.42 (200)
Ask (Size)
134.00 (100)
Prev. Close
131.91
Today's Range
130.30 - 132.76
52wk Range
96.06 - 134.00
Shares Outstanding
N/A
Dividend Yield
3.04%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BIOCHINA2026 – Fusion Forward: Uniting the Global Biopharma Community in Suzhou
November 15, 2025
Via
Press Release Distribution Service
Trump Unveils $200 Billion Trade Deal With Switzerland And Liechtenstein To Cull $38.5 Billion US Goods Deficit By 2028
↗
November 15, 2025
President Donald Trump announced a framework for a trade deal with Switzerland and Liechtenstein on Friday.
Via
Benzinga
Topics
Government
Performance
YTD
+35.1%
+35.1%
1 Month
+0.4%
+0.4%
3 Month
+5.8%
+5.8%
6 Month
+18.6%
+18.6%
1 Year
+27.4%
+27.4%
More News
Read More
AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines
November 14, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Product Recall
Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence
↗
November 10, 2025
Via
Stocktwits
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
November 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
BIOCHINA2026 – Fusion Forward: Uniting the Global Biopharma Community in Suzhou
November 14, 2025
Via
Get News
AI Revolutionizes Cardiovascular Clinical Trials: A Leap Towards Cheaper, Faster Drug Development
November 13, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Novartis' Investigational Medicine Shows Potent Activity Against Drug-Resistant Malaria Strains
↗
November 13, 2025
Via
Benzinga
Eledon Pharmaceuticals Stock Plunges Following $50 Million Public Offering
November 12, 2025
Via
MarketMinute
Topics
Initial Public Offering
Intellectual Property
Regulatory Compliance
AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps
November 10, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
November 05, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Intellectual Property
Celcuity Eyeing Cancer Treatment Riddle. Stock Flys 534% This Year.
↗
November 05, 2025
Via
Investor's Business Daily
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
November 04, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades
↗
November 03, 2025
Via
Benzinga
iShares Core MSCI EAFE ETF (IEFA) Focuses on Developed Markets While Vanguard FTSE All-World ex-US ETF (VEU) Looks Globally
↗
November 03, 2025
Via
The Motley Fool
Topics
ETFs
Trump Offers Help To 'Dilbert' Creator's Cancer Fight
↗
November 03, 2025
Via
Benzinga
Topics
Government
The Vanguard FTSE Developed Markets ETF (VEA) Offers Broader Diversification Than the SPDR Portfolio Developed World ex-US ETF (SPDW)
↗
November 02, 2025
Via
The Motley Fool
Topics
ETFs
Vanguard VEA ETF Boasts Broader Portfolio Than State Street's SPDR SPDW
↗
November 02, 2025
Via
The Motley Fool
Topics
ETFs
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
November 01, 2025
Via
TokenRing AI
Topics
Animal Testing
Artificial Intelligence
Economy
The AI Imperative: Why Rapid Upskilling is Non-Negotiable for Pharma’s Future
October 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
October 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Supply Chain
AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
October 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Intellectual Property
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
October 31, 2025
Via
TokenRing AI
Topics
Animal Testing
Artificial Intelligence
Economy
Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think)
↗
October 31, 2025
Via
The Motley Fool
Here's My Favorite Passive Income Investment
↗
October 31, 2025
Via
The Motley Fool
Topics
ETFs
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 131.26
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 11/14/25 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.